Rezultati - Cools, Jan

When splicing turns bad od Cools, Jan

Polni tekst Polni tekst Polni tekst

A fly’s view of the hematopoietic niche od Cools, Jan

Polni tekst Polni tekst Polni tekst

Using the hemoglobin switch for the treatment of sickle cell disease od Cools, Jan

Polni tekst Polni tekst Polni tekst

Genetic and epigenetic studies offer new therapeutic options for the treatment of T-cell acute lymphoblastic leukemia od Cools, Jan

Polni tekst Polni tekst Polni tekst

Improvements in the survival of children and adolescents with acute lymphoblastic leukemia od Cools, Jan

Polni tekst Polni tekst Polni tekst

Detection of clonal blood cells with specific chromosomal abnormalities in the general population od Cools, Jan

Polni tekst Polni tekst Polni tekst

Primetime for chemotherapy in acute myeloid leukemia od Cools, Jan

Polni tekst Polni tekst Polni tekst

In memory of Tessa Holyoake and Her Work on Chronic Myeloid Leukemia Stem Cells od Cools, Jan

Polni tekst Polni tekst Polni tekst

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia od Cools, Jan

Polni tekst Polni tekst

New flow cytometry in hematologic malignancies od Cools, Jan, Vandenberghe, Peter

Polni tekst Polni tekst Polni tekst

New opportunities and new problems for acute myeloid leukemia treatment od Lahortiga, Idoya, Cools, Jan

Polni tekst Polni tekst Polni tekst

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia od Degryse, Sandrine, Cools, Jan

Polni tekst Polni tekst Polni tekst

The origin of relapse in pediatric T-cell acute lymphoblastic leukemia od Vicente, Carmen, Cools, Jan

Polni tekst Polni tekst Polni tekst

The First Year of HemaSphere and Many More to Come od Engert, Andreas, Cools, Jan

Polni tekst Polni tekst Polni tekst

Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies od Lodewijckx, Inge, Cools, Jan

Polni tekst Polni tekst Polni tekst

The Fifth Year of HemaSphere od Cools, Jan, Engert, Andreas

Polni tekst Polni tekst Polni tekst

Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic Leukemia od Segers, Heidi, Cools, Jan

Polni tekst Polni tekst Polni tekst

The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220 od Pauwels, Daphnie, Sweron, Bram, Cools, Jan

Polni tekst Polni tekst Polni tekst

JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia od de Bock, Charles E., Cools, Jan

Polni tekst Polni tekst Polni tekst

The Updated European Hematology Association Research Roadmap od Engert, Andreas, Cerisoli, Francesco, Cools, Jan

Polni tekst Polni tekst Polni tekst